Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Hemasri Tokala , Jagadeesh K Kalavakunta , Heather Laird-Fick , et al Added: 3 years ago
Abstract Cardiac paragangliomas are the rarest primary cardiac tumours and account for less than one percent of cases. A 24-year-old man presented with complaints of sudden onset of chest pain. The pain started suddenly when he was skiing halfway down the slope and went into a tuck position. Physical examination was significant for elevated jugular venous distension. His electrocardiogram… View more
Author(s): Maria Min-Young Kim Added: 2 years ago
In this interview, Dr Maria Min-Young Kim (Imperial College Healthcare NHS Trust, London, UK) discusses the results of the GANGLIA-AF Trial, a study that aimed to determine the role of ectopy-triggering ganglionated plexus ablation (ET-GP) in the treatment of Atrial Fibrillation. Questions: 1. Please summarise the main aims, study design and endpoints of this trial? 2. What were your key… View more
Author(s): Lindsay A Smith , Amit Bhan , Mark J Monaghan Added: 3 years ago
The field of non-coronary cardiac intervention is undergoing rapid expansion, driven by advances in technology and increasing demand for alternative, non-surgical therapies for common structural heart diseases. As a result, the volume, variety and complexity of percutaneous catheter-based procedures being performed in cardiac catheterisation laboratories are increasing. Traditionally, fluoroscopy… View more
Author(s): Shahid Aziz , David R Ramsdale Added: 3 years ago
Chronic total occlusions (CTOs) remain one of the greatest challenges facing interventional cardiologists and represent 10-15% of all percutaneous coronary intervention (PCI) procedures performed.1 Not only are procedures more prolonged and involve additional radiation exposure, but audit data from the British Cardiovascular Intervention Society for 2005 reported a procedural success of only 68%… View more
Author(s): Leonardo Guimaraes , David del Val , Sebastien Bergeron , et al Added: 3 years ago
Major advances in heart failure (HF) management have been achieved over the past three decades, yet it remains a syndrome with high morbidity and mortality, poor quality of life and high healthcare costs. Despite all advances in medical/device therapy, many HF patients continue to deteriorate, leading to poor quality of life and high rehospitalisation and mortality rates.1 The recent European… View more